BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15986337)

  • 1. Clinical images: Anetoderma in systemic lupus erythematosus with antiphospholipid antibodies.
    Venhoff N; Miehle N; Jüttner E; Peter HH; Walker UA
    Arthritis Rheum; 2005 Jul; 52(7):2228. PubMed ID: 15986337
    [No Abstract]   [Full Text] [Related]  

  • 2. Anetoderma associated with systemic lupus erythematosus and antiphospholipid antibodies.
    Sabio JM; Tercedor J; Massare E; Jiménez-Alonso J
    Lupus; 2004; 13(10):826-7. PubMed ID: 15540519
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anetoderma during antiphospholipid syndrome. 3 cases].
    Disdier P; Christides C; Andrac-Meyer L; Rojat-Habib MC; Aillaud MF; Swiader L; Weiller-Merli C; Berbis P; Harlé JR; Weiller PJ
    Ann Dermatol Venereol; 1996; 123(12):800-3. PubMed ID: 9636765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies and anetoderma: are they associated?
    Stephansson EA; Niemi KM
    Dermatology; 1995; 191(3):204-9. PubMed ID: 8534938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus.
    Bilen N; Bayramgürler D; Sikar A; Erçin C; Yilmaz A
    Lupus; 2003; 12(9):714-6. PubMed ID: 14514137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies.
    Alvarez-Cuesta CC; Raya-Aguado C; Fernández-Rippe ML; Sánchez TS; Pérez-Oliva N
    Dermatology; 2001; 203(4):348-50. PubMed ID: 11752829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary anetoderma: a cutaneous marker of antiphospholipid antibodies.
    Staiger H; Saposnik M; Spiner RE; Schroh RG; Corbella MC; Hassan ML
    Skinmed; 2011; 9(3):168-71. PubMed ID: 21675496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies.
    Montilla C; Alarcón-Segovia D
    Lupus; 2000; 9(7):545-7. PubMed ID: 11035422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anetoderma and lupus erythematosus. Study of 2 cases].
    Hassan ML; Schroh RG; Konopka H
    Med Cutan Ibero Lat Am; 1987; 15(4):341-9. PubMed ID: 3320631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Armor-like calcinosis in systemic lupus erythematosus.
    Honma M; Komatsu S; Takahashi I; Iizuka H
    J Dermatol; 2011 Oct; 38(10):1021-4. PubMed ID: 21366678
    [No Abstract]   [Full Text] [Related]  

  • 11. Bithalamic stroke in a patient with systemic lupus erythematosus, positive antiphospholipid antibodies and warfarin use.
    Chang RS; Mak HK; Mak WW; Mok MY
    Int J Rheum Dis; 2012 Aug; 15(4):e76-7. PubMed ID: 22898232
    [No Abstract]   [Full Text] [Related]  

  • 12. Anetodermic lupus panniculitis and antiphospholipid antibodies: report of three cases.
    Marzano A; Vanotti M; Alessi E
    Acta Derm Venereol; 2004; 84(5):385-8. PubMed ID: 15370706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anetoderma and its prothrombotic abnormalities.
    Sparsa A; Piette JC; Wechsler B; Amoura Z; Francès C
    J Am Acad Dermatol; 2003 Dec; 49(6):1008-12. PubMed ID: 14639377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middermal elastolysis in two patients with lupus erythematosus.
    Boyd AS; King LE
    Am J Dermatopathol; 2001 Apr; 23(2):136-8. PubMed ID: 11285409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophic macules and soft papules in a 24-year-old woman. Anetoderma associated with antiphospholipid antibodies.
    Pascual JC; Giménez E; Sivera F; Martinez A
    Arch Dermatol; 2007 Jan; 143(1):109-14. PubMed ID: 17224553
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupoid sclerosis: what is the role of antiphospholipid antibodies?
    Lima I; Melo A; Brandi IV; Costa O; Santiago M
    J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus.
    Mehta BM; Kiani AN; Chen C; Jani J; Kickler TS; Petri M
    Am J Hematol; 2010 Jan; 85(1):83-5. PubMed ID: 20029948
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic lupus erythematosus-associated anetoderma and anti-phospholipid antibodies.
    Fernández-Galar M; España A; Lloret P
    Clin Exp Dermatol; 2003 Jan; 28(1):39-42. PubMed ID: 12558628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary disease during subacute lupus erythematosus].
    Parodi A; Drosera M; Barbieri L; Rebora A
    Ann Dermatol Venereol; 1998 Mar; 125(3):203. PubMed ID: 9747252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.